Barclays PLC Purchases 7,978 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)
Barclays PLC increased its stake in shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM – Free Report) by 96.0% in the fourth quarter, HoldingsChannel reports. The firm owned 16,286 shares of the company’s stock after buying an additional 7,978 shares during the period. Barclays PLC’s holdings in Contineum Therapeutics were worth $239,000 as of its most recent […]
Barclays PLC increased its stake in shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM – Free Report) by 96.0% in the fourth quarter, HoldingsChannel reports. The firm owned 16,286 shares of the company’s stock after buying an additional 7,978 shares during the period. Barclays PLC’s holdings in Contineum Therapeutics were worth $239,000 as of its most recent […]
